IRIS
VALENSISE, HERBERT CARMELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.440
AS - Asia 3.083
EU - Europa 2.171
SA - Sud America 524
AF - Africa 43
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 21.281
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.363
SG - Singapore 1.965
IT - Italia 681
CN - Cina 504
BR - Brasile 426
DE - Germania 273
IE - Irlanda 239
HK - Hong Kong 190
UA - Ucraina 146
RU - Federazione Russa 143
VN - Vietnam 135
GB - Regno Unito 124
PL - Polonia 120
FI - Finlandia 109
FR - Francia 109
SE - Svezia 69
NL - Olanda 57
AR - Argentina 43
CA - Canada 38
IN - India 36
KR - Corea 36
JP - Giappone 35
ID - Indonesia 33
CZ - Repubblica Ceca 30
MX - Messico 26
BD - Bangladesh 23
TR - Turchia 23
IQ - Iraq 21
ES - Italia 19
PS - Palestinian Territory 16
AU - Australia 14
CO - Colombia 14
ZA - Sudafrica 14
EC - Ecuador 13
AT - Austria 11
BE - Belgio 10
VE - Venezuela 9
MA - Marocco 8
NP - Nepal 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
IR - Iran 6
PK - Pakistan 6
PY - Paraguay 6
EG - Egitto 5
GT - Guatemala 5
LT - Lituania 5
MY - Malesia 5
RO - Romania 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
DZ - Algeria 4
IL - Israele 4
KZ - Kazakistan 4
HU - Ungheria 3
PE - Perù 3
RS - Serbia 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
BY - Bielorussia 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GR - Grecia 2
HN - Honduras 2
KE - Kenya 2
LB - Libano 2
OM - Oman 2
PH - Filippine 2
PT - Portogallo 2
SA - Arabia Saudita 2
TN - Tunisia 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
CR - Costa Rica 1
DK - Danimarca 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
GI - Gibilterra 1
GY - Guiana 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
MK - Macedonia 1
MR - Mauritania 1
NG - Nigeria 1
NO - Norvegia 1
NR - Nauru 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
Totale 21.278
Salva come PNG Salva come JPEG
Città #
Wilmington 3.897
Houston 3.495
Woodbridge 3.391
Singapore 629
Fairfield 526
Chandler 404
Ashburn 351
Ann Arbor 276
Dublin 239
Beijing 210
Seattle 208
Rome 201
Hong Kong 190
New York 168
Cambridge 165
Medford 151
Los Angeles 131
Jacksonville 112
Kraków 104
Santa Clara 104
Council Bluffs 99
Zhengzhou 98
Dearborn 79
The Dalles 79
Boardman 78
Helsinki 72
Lawrence 69
Ho Chi Minh City 61
Cedarhurst 55
Dallas 55
Buffalo 51
Milan 48
North Bergen 47
São Paulo 45
San Jose 35
San Diego 33
Redondo Beach 30
Olomouc 27
Chicago 25
Hanoi 25
London 25
Moscow 25
Shanghai 23
Munich 22
Monte Vista 21
Mülheim 21
Naples 20
Phoenix 19
Tokyo 18
Manchester 17
Montreal 17
Brooklyn 16
Chennai 16
Denver 16
Bologna 15
Florence 15
Turin 15
Amsterdam 14
Nuremberg 14
Boston 13
Guangzhou 13
Orem 13
Poplar 13
San Francisco 13
Stockholm 13
Rio de Janeiro 12
Ankara 11
Baghdad 11
Johannesburg 11
Warsaw 11
Atlanta 10
Brussels 10
Dhaka 10
Frankfurt am Main 10
Nanjing 10
Jakarta 9
Menlo Park 9
Norwalk 9
Salt Lake City 9
Seoul 9
Ascoli Piceno 8
Campinas 8
Hefei 8
Lauterbourg 8
Melbourne 8
Mexico City 8
Querétaro 8
Redwood City 8
Brasília 7
Curitiba 7
Manaus 7
Quito 7
Verona 7
Buenos Aires 6
Cartagena 6
Falls Church 6
Lappeenranta 6
Porto Alegre 6
Salvador 6
San Mateo 6
Totale 16.782
Salva come PNG Salva come JPEG
Nome #
Are Gestational and Essential Hypertension Similar? Left Ventricular Geometry and Diastolic Function 524
Medical treatment of early-onset mild gestational hypertension reduces total peripheral vascular resistance and influences maternal and fetal complications 509
Body composition during normal pregnancy: reference ranges 496
Abnormal maternal cardiac function precedes the clinical manifestation of fetal growth restriction 488
Fetal subcutaneous tissue thickness (SCTT) in healthy and gestational diabetic pregnancies 477
Normal fetal growth in women with antiphospholipid syndrome treated with high-dose intravenous immunoglobulin (IVIG) 461
Assessment of total vascular resistance and total body water in normotensive women during the first trimester of pregnancy. A key for the prevention of preeclampsia 450
Left ventricular midwall mechanics at 24 weeks' gestation in high-risk normotensive pregnant women: Relationship to placenta-related complications of pregnancy 447
Could birthweight prediction models be improved by adding fetal subcutaneous tissue thickness? 447
PP065. Assessment of total vascular resistance and total body water in normotensive women during the first trimester of pregnancy in order to predict hypertensive complications 430
Multifrequency bioelectrical impedance analysis in women with a normal and hypertensive pregnancy 429
Molecular basis of thyrotropin and thyroid hormone action during implantation and early development 427
Mild thyroid abnormalities and recurrent spontaneous abortion: diagnostic and therapeutical approach 421
Maternal and fetal hemodynamic effects induced by nitric oxide donors and plasma volume expansion in pregnancies with gestational hypertension complicated by intrauterine growth restriction with absent end-diastolic flow in the umbilical artery 415
Maternal total vascular resistance and concentric geometry: A key to identify uncomplicated gestational hypertension 411
The computerized fetal heart rate analysis in post-term pregnancy identifies patients at risk for fetal distress in labour 408
Diagnostic evaluation of women experiencing repeated in vitro fertilization failure. 404
Ultrasound-determined fetal subcutaneous tissue thickness for a birthweight prediction model 401
Pregnancy outcome in recurrent spontaneous abortion associated with antiphospholipid antibodies: a comparative study of intravenous immunoglobulin versus prednisone plus low-dose aspirin 385
Molecular basis of thyrotropin and thyroid hormone action during implantation and early development 385
Screening for preeclampsia in the first trimester: role of maternal hemodynamics and bioimpedence in non obese patients 384
Increased expression of low-affinity insulin receptor isoform and insulin/insulin-like growth factor-I hybrid receptors in term placenta from insulin-resistant women with gestational hypertension 383
Normal fetal growth in women with antiphospholipid syndrome treated with high dose intravenous immunoglobulins 375
Nifedipine-induced changes in body composition in hypertensive patients at term 371
The fetal body compartments and their detection during pregnancy. A review 363
GSTA1 gene variation associated with gestational hypertension and its involvement in pregnancy-related pathogenic conditions 359
Schauta-Amreich Operation vs Piver II Procedure with Pelvic Lymphadenectomy for Cervical Cancer 358
Total body water estimation and maternal cardiac systolic function assessment in normal and gestational hypertensive pregnant women 348
Maternal body composition at term gestation and birth weight: is there a link? 346
Maternal cardiac systolic function and total body water estimation in normal and gestational hypertensive women 339
Adjuvant vemurafenib in resected, BRAFV600mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial 338
Fetal monitoring indications for delivery and 2-year outcome in 310 infants with fetal growth restriction delivered before 32 weeks' gestation in the TRUFFLE study 271
Foetal heart rate deceleration with combined spinal-epidural analgesia during labour: A maternal haemodynamic cardiac study 251
The influence of doctor-patient and midwife-patient relationship in quality care perception of Italian pregnant women: An exploratory study 248
Assessment of venous hemodynamics and volume homeostasis during pregnancy: recommendations of the International Working Group on Maternal Hemodynamics 183
Correlation between maternal body composition and haemodynamic changes in pregnancy: different profiles for different hypertensive disorders 178
Fetal growth restriction and maternal cardiac function 173
Assessment of arterial function in pregnancy: recommendations of the International Working Group on Maternal Hemodynamics 170
The maternal cardiovascular effect of carbetocin compared to oxytocin in women undergoing caesarean section 164
A developmental approach to the prevention of hypertension and kidney disease: a report from the Low Birth Weight and Nephron Number Working Group 163
Antenatal Care of Preeclampsia: From the Inverted Pyramid to the Arrow Model? 162
Maternal hemodynamics early in labor: a possible link with obstetric risk? 162
Clinical opinion: the diagnosis and management of suspected fetal growth restriction: an evidence-based approach 161
Comparative analysis of 2-year outcomes in GRIT and TRUFFLE trials 160
Maternal Hemodynamics from Preconception to Delivery: Research and Potential Diagnostic and Therapeutic Implications: Position Statement by Italian Association of Pre-Eclampsia and Italian Society of Perinatal Medicine 157
Severe fetal growth restriction at 26–32 weeks: key messages from the TRUFFLE study 153
Methods and considerations concerning cardiac output measurement in pregnant women: recommendations of the International Working Group on Maternal Hemodynamics 152
Ultrasonographic evaluation of the second stage of labor. Predictive parameters for a successful vaginal delivery with or without neuraxial analgesia: a pilot study 152
Is middle cerebral artery Doppler related to neonatal and 2-year infant outcome in early fetal growth restriction? 150
Research priorities for the future health of multiples and their families: The Global Twins and Multiples Priority Setting Partnership 148
Chronic pain management in pregnancy and lactation 147
Hypertension in pregnancy and endothelial activation: An emerging risk factor for cardiovascular disease 145
The Impact of Kidney Development on the Life Course: A Consensus Document for Action 145
Hemodynamic guided treatment of hypertensive disorders in pregnancy: is it time to change our mind? 144
Women with endometriosis at first pregnancy have an increased risk of adverse obstetric outcome 140
Friendly help for clinical use of maternal hemodynamics 139
Preterm delivery and elevated maternal total vascular resistance: signs of suboptimal cardiovascular adaptation to pregnancy? 137
Restricted physical activity in pregnancy reduces maternal vascular resistance and improves fetal growth 137
Pregnancy complications in chronic hypertensive patients are linked to pre-pregnancy maternal cardiac function and structure 134
Acetylsalicylic acid in pregnant women with chronic hypertension 133
Outcome in early-onset fetal growth restriction is best combining computerized fetal heart rate analysis with ductus venosus Doppler: insights from the Trial of Umbilical and Fetal Flow in Europe 133
Optimization of the viability of stem cells derived from umbilical cord blood after maternal supplementation with DHA during the second or third trimester of pregnancy: Study protocol for a randomized controlled trial 132
Persistent maternal cardiac dysfunction after preeclampsia identifies patients at risk for recurrent preeclampsia 132
Functional hemodynamic testing in pregnancy: recommendations of the International Working Group on Maternal Hemodynamics 129
Hemodynamic Prediction and Stratification of Hypertensive Disorders of Pregnancy: A Dream That Is Coming True? 129
Early and Late preeclampsia: Two different maternal hemodynamic states in the latent phase of the disease 124
Preeclampsia: the role of persistent endothelial cells in uteroplacental arteries. Brosens I, Brosens JJ, Muter J, Puttemans P, Benagiano G. Am J Obstet Gynecol 2019;221:219-26 121
Effect of a nitric oxide donor on maternal hemodynamics in fetal growth restriction 113
Distinction between SGA and FGR by means of fetal umbilical vein flow and maternal hemodynamics 111
Treatment of pregnancies complicated by intrauterine growth restriction with nitric oxide donors increases placental expression of Epidermal Growth Factor-Like Domain 7 and improves fetal growth: A pilot study 101
Fetal Umbilical Vein Flow in the Classification of Fetuses with Growth Restriction 99
Prenatal and postnatal imaging of multiple intracranial lipomas: Report of a Case 99
Circulating EGFL7 distinguishes between IUGR and PE: an observational case–control study 97
Cardiac Function 90
Systemic vascular resistance may influence the outcome of in vitro fertilization 87
Hemodynamic maladaptation and left ventricular dysfunction in chronic hypertensive patients at the beginning of gestation and pregnancy complications: a case control study 84
A practical approach to the management of thyroid dysfunction during pregnancy 80
Hemodynamic assessment in patients with preterm premature rupture of the membranes (pPROM) 79
Are Chlamydia Trachomatis and Neisseria Gonorrhoeae Screenings in Pregnant Women Being Properly Performed? A Single-Center Retrospective Observational Study in Italy 77
Restricted physical activity in pregnancy reduces maternal vascular resistance and improves fetal growth 76
Maternal Cardiovascular Dysfunction is Associated with Hypoxic Cerebral and Umbilical Doppler Changes 74
G2. Low pregestational fat mass and subsequent maternal cardiovascular maladaptation in early pregnancy. The missing link for preeclampsia 71
D2. Screening of preeclampsia (PE) in the first trimester: high total vascular resistance (TVR) with a reduced fat mass increase the risk in normo BMI patients 70
The “Preeclampsia and Hypertension Target Treatment” (“PYTT”) study: a multicenter prospective study to evaluate the effectiveness of the antihypertensive therapy based on maternal hemodynamic findings 70
Screening for pre-eclampsia in the first trimester: role of maternal hemodynamics and bioimpedance in non-obese patients 69
Maternal peripheral vascular resistance at mid gestation in chronic hypertension as a predictor of fetal growth restriction 67
Correlation between maternal body composition and haemodynamic changes in pregnancy: different profiles for different hypertensive disorders 66
The p63 C-terminus is essential for murine oocyte integrity 66
F1. Is there a correlation between total body water distribution and haemodynamic changes during pregnancy? 65
Maternal cardiovascular profile is altered in the preclinical phase of normotensive early and late intrauterine growth restriction 60
Definition, identification, implications and management of hypodynamic hypertension in pregnancy 59
C-peptide and insulin levels at 24-30 weeks' gestation: An increased risk of adverse pregnancy outcomes? 59
Preterm delivery and elevated maternal total vascular resistance: signs of suboptimal cardiovascular adaptation to pregnancy? 57
G1. Maternal haemodynamics assessment in preterm delivery: two different haemodynamic profiles 56
Are HLA-G polymorphisms associated to recurrent pregnancy loss? 55
SARS-CoV-2, Endothelial Dysfunction, and the Renin-Angiotensin System (RAS): A Potentially Dangerous Triad for the Development of Pre-Eclampsia 51
Restricted physical activity and maternal rest improve fetal growth: should we look for the reason in the cardiovascular modifications? 51
Pre-eclampsia: One name, two conditions - The case for early and late disease being different 50
Cell immunity and recurrent miscarriage 49
Maternal hemodynamics for the identification of early fetal growth restriction in normotensive pregnancies 49
Totale 20.845
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.646
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.646
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.026 0 0 0 0 0 0 467 281 52 124 78 24
2021/2022692 32 96 34 36 19 34 43 32 45 83 44 194
2022/20231.182 169 98 37 116 111 246 99 90 117 18 68 13
2023/2024462 53 9 14 11 30 125 28 13 10 18 11 140
2024/20253.447 41 425 237 114 66 415 310 154 368 188 627 502
2025/20262.700 371 193 581 604 541 243 167 0 0 0 0 0
Totale 21.670